• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低睾酮生物利用度与接受前列腺活检的患者前列腺癌诊断有关。

Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.

机构信息

Department of Urology, Hospital Clínic de Barcelona, Barcelona, Spain.

出版信息

World J Urol. 2012 Jun;30(3):361-5. doi: 10.1007/s00345-011-0741-9. Epub 2011 Aug 11.

DOI:10.1007/s00345-011-0741-9
PMID:21833558
Abstract

INTRODUCTION

Relationship between prostate cancer (PCa) and testosterone (T) is controversial. Conflicting evidence has been published about T levels and development of PCa.

AIM

(1) To determine the relationship between hormone levels and the diagnosis of PCa. (2) To specifically focus on the relationship between PCa and T in men classified as biochemically hypogonadal.

MATERIALS AND METHODS

Prospective analysis of 1,000 transrectal ultrasound guided prostate biopsies (5 + 5 cores biopsies) between September 2007 and January 2010 in one center. Indication for prostate biopsy was suspicion of PCa on the basis of elevated prostate-specific antigen (PSA) and/or digital rectal examination (DRE). Serum testosterone and sex hormones binding globulin (SHBG) were determined in these patients. Of 557 men, the data were sufficient for further analysis. Age, body mass index (BMI), smoking/drinking habits, PSA, free PSA, PSA density, prostate volume, number of previous biopsies, DRE, and hormone levels were prospectively recorded.

RESULTS

No relationship was found between T and PCa (449 ± 167 ng/dL in PCa versus 437 ± 169 ng/dL in non-PCa). SHBG was significantly higher in patients with PCa (51 ± 27 ng/dL in PCa vs. 44 ± 18 ng/dL in non-PCa). In hypogonadal men, T levels correlated with the PCa (235 ± 95 ng/dL in men with PCa versus 270 ± 58 ng/dL in men without PCa, P = 0.004).

CONCLUSIONS

T levels were comparable in men with and without PCa, but SHBG levels were significantly higher in men with PCa. In men with low T, the men with PCa had a lower serum T levels and a lower prostate volume than the men without PCa.

摘要

简介

前列腺癌(PCa)与睾丸激素(T)之间的关系存在争议。关于 T 水平与 PCa 发展之间的关系,已经发表了相互矛盾的证据。

目的

(1)确定激素水平与 PCa 诊断之间的关系。(2)专门关注被归类为生物性性腺功能减退的男性中 PCa 与 T 之间的关系。

材料和方法

对 2007 年 9 月至 2010 年 1 月在一个中心进行的 1000 例经直肠超声引导前列腺活检(5+5 芯活检)进行前瞻性分析。前列腺活检的指征是基于前列腺特异性抗原(PSA)升高和/或直肠指检(DRE)怀疑 PCa。这些患者测定血清睾丸激素和性激素结合球蛋白(SHBG)。在 557 名男性中,有足够的数据进行进一步分析。前瞻性记录年龄、体重指数(BMI)、吸烟/饮酒习惯、PSA、游离 PSA、PSA 密度、前列腺体积、既往活检次数、DRE 和激素水平。

结果

T 与 PCa 之间未发现相关性(PCa 中为 449±167ng/dL,非 PCa 中为 437±169ng/dL)。PCa 患者的 SHBG 明显较高(PCa 中为 51±27ng/dL,非 PCa 中为 44±18ng/dL)。在性腺功能减退的男性中,T 水平与 PCa 相关(PCa 中为 235±95ng/dL,非 PCa 中为 270±58ng/dL,P=0.004)。

结论

T 水平在有和没有 PCa 的男性中相似,但 SHBG 水平在有 PCa 的男性中明显较高。在 T 水平较低的男性中,患有 PCa 的男性的血清 T 水平和前列腺体积低于不患有 PCa 的男性。

相似文献

1
Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy.低睾酮生物利用度与接受前列腺活检的患者前列腺癌诊断有关。
World J Urol. 2012 Jun;30(3):361-5. doi: 10.1007/s00345-011-0741-9. Epub 2011 Aug 11.
2
Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.较高的性激素结合球蛋白水平和较低的生物可利用睾酮水平与前列腺穿刺活检时前列腺癌的检出相关。
Scand J Urol. 2013 Aug;47(4):282-9. doi: 10.3109/00365599.2012.747562. Epub 2012 Nov 27.
3
The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.直肠指检在肥胖患者前列腺癌检测中作为诊断试验的作用。
J BUON. 2015 Nov-Dec;20(6):1601-5.
4
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.低睾酮水平与治疗前前列腺癌男性的不良预后因素有关。
BJU Int. 2012 Dec;110(11 Pt B):E541-6. doi: 10.1111/j.1464-410X.2012.11232.x. Epub 2012 May 15.
5
Utility of digital rectal examination, serum prostate specific antigen, and transrectal ultrasound in the detection of prostate cancer: a developing country perspective.直肠指检、血清前列腺特异性抗原及经直肠超声在前列腺癌检测中的应用:发展中国家视角
Asian Pac J Cancer Prev. 2014;15(7):3087-91. doi: 10.7314/apjcp.2014.15.7.3087.
6
Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all?前列腺特异性抗原在欧洲HIV阳性队列中的预测价值:一种方法适用于所有人吗?
Antivir Ther. 2016;21(6):529-534. doi: 10.3851/IMP3026. Epub 2016 Jan 29.
7
The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤ 15 ng/ml and normal digital rectal examination: a 10-year prospective follow-up study of 427 consecutive patients.经直肠超声引导活检对前列腺特异抗原(PSA)水平≤15ng/ml 且直肠指检正常的 70 岁以上患者的预后价值:427 例连续患者 10 年前瞻性随访研究。
Urol Oncol. 2013 Nov;31(8):1489-96. doi: 10.1016/j.urolonc.2012.04.005. Epub 2012 May 15.
8
Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.前列腺体积指数能够在直肠指检正常且前列腺特异性抗原值<10 ng/mL的患者中区分前列腺慢性炎症和前列腺癌:564例未经活检病例的结果
Urol Int. 2019;103(4):415-422. doi: 10.1159/000502659. Epub 2019 Aug 29.
9
Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.在前列腺癌筛查中使用低游离 PSA 与总 PSA 比值:血清 PSA 水平<4.0ng/mL 的巴西男性中的检出率、临床和病理发现。
BJU Int. 2012 Dec;110(11 Pt B):E653-7. doi: 10.1111/j.1464-410X.2012.11398.x. Epub 2012 Aug 14.
10
[Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].[前列腺特异性抗原在确定初次前列腺活检指征中的预后意义]
Urologiia. 2018 Jul(3):92-97.

引用本文的文献

1
The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy.血清睾酮水平在首次前列腺活检时非典型小腺泡增生患者中作为前列腺癌预测指标的作用。
Asian J Androl. 2018 Jan-Feb;20(1):15-18. doi: 10.4103/aja.aja_17_17.
2
Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result.血清睾酮作为前列腺癌首次活检阴性且前列腺特异性抗原(PSA)>4 ng/mL 或前列腺上皮内瘤变(PIN)活检结果男性患者第二次前列腺活检的生物标志物。
Int Braz J Urol. 2016 Sep-Oct;42(5):925-931. doi: 10.1590/S1677-5538.IBJU.2015.0167.
3

本文引用的文献

1
The Effect of Castration on Benign Hypertrophy of the Prostate in Man.去势对男性前列腺良性增生的影响。
J Urol. 2017 Feb;197(2S):S66-S75. doi: 10.1016/j.juro.2016.10.075. Epub 2016 Dec 21.
2
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.EAU 前列腺癌指南。第 1 部分:局限性疾病的筛查、诊断和治疗。
Eur Urol. 2011 Jan;59(1):61-71. doi: 10.1016/j.eururo.2010.10.039. Epub 2010 Oct 28.
3
Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk.
Low serum testosterone levels are predictive of prostate cancer.
血清睾酮水平低可预测前列腺癌。
World J Urol. 2013 Apr;31(2):247-52. doi: 10.1007/s00345-011-0793-x. Epub 2011 Nov 9.
评估血清睾酮与前列腺特异性抗原比值作为前列腺癌风险的预测指标。
BJU Int. 2010 Feb;105(4):481-4. doi: 10.1111/j.1464-410X.2009.08761.x. Epub 2009 Aug 13.
4
Rapidly shifting concepts regarding androgens and prostate cancer.关于雄激素与前列腺癌的概念正在迅速转变。
ScientificWorldJournal. 2009 Jul 27;9:685-90. doi: 10.1100/tsw.2009.80.
5
Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.转变睾酮与前列腺癌的范式:饱和模型及雄激素依赖生长的局限性
Eur Urol. 2009 Feb;55(2):310-20. doi: 10.1016/j.eururo.2008.09.024. Epub 2008 Sep 24.
6
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.男性迟发性性腺功能减退症的调查、治疗和监测:ISA、IS-SAM、EAU、EAA 和 ASA 建议。
Eur Urol. 2009 Jan;55(1):121-30. doi: 10.1016/j.eururo.2008.08.033. Epub 2008 Aug 30.
7
Testosterone levels in benign prostatic hypertrophy and prostate cancer.良性前列腺增生症和前列腺癌中的睾酮水平。
Urol Int. 2008;80(2):134-40. doi: 10.1159/000112602. Epub 2008 Mar 19.
8
Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.内源性性激素与前列腺癌:18项前瞻性研究的协作分析
J Natl Cancer Inst. 2008 Feb 6;100(3):170-83. doi: 10.1093/jnci/djm323. Epub 2008 Jan 29.
9
Testosterone deficiency and prostate cancer: emerging recognition of an important and troubling relationship.睾酮缺乏与前列腺癌:对一种重要且棘手关系的新认识。
Eur Urol. 2007 Sep;52(3):623-5. doi: 10.1016/j.eururo.2007.04.005. Epub 2007 Apr 9.
10
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.前列腺特异性抗原水平为4.0 ng/mL或更低的性腺功能减退男性中前列腺癌的患病率。
Urology. 2006 Dec;68(6):1263-7. doi: 10.1016/j.urology.2006.08.1058.